Prot# A 9391010: A Phase 2, Randomized, Double-Blind Assessment of Efficacy and Safety of PF-04171327(1, 5, 10, 15 MG Dose, Daily) Compared to 5 MG and 10 MG Prednisone Daily and Placebo Daily in Subjects with Rheumatoid Arthritis Over an 8 Week Period Fo

Project: Research project

Project Details

Effective start/end date11/8/1111/8/14


  • Pfizer Inc. (A 9391010)